Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response

Leukemia

Volumn 11, Issue 10, 1997, Pages 1732-1741

  Foroni, L ^a   Coyle, L A ^a,b   Papaioannou, M ^a   Yaxley, J C ^a   Cole Sinclair, M F ^a,c   Chim, J S ^a,d   Cannell, P ^a,e   Seeker Walker, L M ^a   Mehta, A B ^a   Prentice, H G ^a   Hoffbrand, A V ^a  

^a ROYAL FREE HOSPITAL   (United Kingdom)

^b ROYAL NORTH SHORE HOSPITAL   (Australia)

^c Alfred Group of Hospitals   (Australia)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

^e ROYAL PERTH HOSPITAL   (Australia)

Author keywords

ALL; CDR3; MRD

Indexed keywords

IMMUNOGLOBULIN HEAVY CHAIN;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; B CELL LEUKEMIA; BONE MARROW; CHILD; CHILDHOOD LEUKEMIA; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN GENE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MOLECULAR GENETICS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RELAPSE;

EID: 16944366700     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400841     Document Type: Article

References (34)

1. Biondi A, Yokota T, Hansen-Hagge T, Rossi V, Giudici G, Maglia O, Basso G, Tell C, Masera G, Bartram CR. Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse. Leukemia 1992; 6: 282-288.
2. Brisco M, Condon J, Sykes P, Neoh SH, Morley AA. Detection and quantification of neoplastic cells in acute lymphoblastic leukemia by use of polymerase chain reaction. Br J Haematol 1991; 79: 211-217.
3. Brisco MJ, Condon J, Hughes E, Neoh S-H, Nicholson I, Sykes P, Tauro J, Ekhert H, Waters K, Toogood I, Seshadri R, Morley A. Prognostic significance of detection of monoclonality in remission marrow in acute lymphoblastic leukemia in childhood. Leukemia 1993; 7: 1514-1520.
4. Brisco MJ, Condon J, Hughes E, Neoh S-H, Sykes P, Seshadri R Toogood I, Waters K, Tauro J, Ekhert H, Morley A. Outcome prediction in childhood acute lymphoblastic leukemia by quantification of residual disease at the end of induction. Lancet 1994; 343: 196-200.
5. Cave H, Guidal C, Rohrlich P, Delfau MH, Broyart A, Lescoeur B, Rahimy C, Fenneteau O, Monplaiserir N, d'Ariol L, Elion J Vilmer E, Grandchamp B. Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of δ and γ T-cell receptor genes Blood 1994; 83: 1892-1902.
6. Ito Y, Wasserman R, Galili N, Reichard BA, Shane S, Lange B, Rovera G. Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with acute lymphoblastic leukemia. J Clin Oncol 1993; 11: 546-553.
7. Kitchingman GR. Residual disease detection in multiple follow-up samples in children with acute lymphoblastic leukemia. Leukemia 1994; 8: 395-401.
8. Potter M, Steward C, Maitland N, Oakhill A. Detection of clonality in childhood B-lineage acute lymphoblastic leukaemia by polymerase chain reaction. Leukemia 1992; 6: 289-294.
9. Potter MN, Steward CG, Oakhill A. The significance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia. Br J Haematol 1993; 83: 412-418.
10. Potter M, Cross N, van Dongen JM, Saglio G, Oakill A, Bartram CCR, Goldman JM. Molecular evidence of minimal residual disease after treatment for leukaemia and lymphoma: reports of the fourth workshop of the molecular Biology/BMT Study Group. Leukemia 1993; 7: 1302-1314.
11. Yamada M, Wasserman R, Lange B, Reichard BA, Womer RB, Rovera G. Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemia cells during the first 18 months of treatment. New Engl J Med 1990; 323: 448-455.
12. Wasserman R, Galili N, Ito Y, Silber JH, Reichard BA, Shane S, Womer RB, Lange B, Rovera G. Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia. J Clin Oncol 1992; 10: 1878-1888.
13. Cole-Sinclair M, Foroni L, Wright F, Mehta A, Prentice HG, Hoffbrand AV. Minimal residual disease in acute lymphoblastic leukemia - PCR analysis of immunoglobulin gene rearrangements. Leuk Lymphoma 1993; 2: 49-58.
14. Nizet Y, Martiat P, Vaerman JL, Philippe M, Widmann C, Staelens JP, Comu G, Ferrant A, Michaux JL, Sokal G. Follow-up of residual disease (MRD) in B lineage acute lymphoblastic leukaemia using a simplified PCR strategy: evolution of MRD rather than detection is correlated with clinical outcome. Br J Haematol 1991; 79: 205-210.
15. Nizet Y, Van Deale S, Lewalle P, Vaerman JL, Philippe M, Vermylen C, Cornu G, Ferrant A, Michaux JL, Martiat P. Long term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogenic IgH probes and the polymerase chain reaction. Blood 1993; 82: 1618-1625.
16. Ito Y, Miyamure K. Clinical significance of minimal residual disease in leukemia detected by polymerase chain reaction: is molecular remission a milestone for achieving a cure? Leuk Lymphoma 1994; 16: 57-64.
17. Bartram CR. Minimal residual disease in ALL. ISH 24th Congress State of the Art Symposia. Br J Haematol 1992; 82: 182-184.
18. Brisco MJ, Hughes E, Neoh SH, Sykes PJ, Bradstock K, Enno A, Szer J, McCaul K, Morley AA. Relationship between minimal residual disease and outcome in adult acute lymphoblastic leukemia. Blood 1996; 87: 5251-5256.
19. Chim JS, Coyle L, Yaxley JC, Cole-Sinclair MF, Cannell PK, Hoffbrand VA, Foroni L. Investigation of minimal residual disease (MRD) by the use of a semi-quantitative multi-step test combination in ALL. Br J Haematol 1996; 90: 104-115.
20. Campana D, Coustan-Smith E, Janossy G. Immunophenotyping in haematological diagnosis. Baillière's Clin Haematol 1990; 3: 889-919.
21. Foroni L, Mason PJ, Luzzatto L. Immunoglobulin and T-cell receptor gene analysis for the investigation of lymphoproliferative disorders. In: Catovsky D (ed). The Leukemic Cell, 2nd edn. Methods in Haematology. Churchill Livingstone: NY, Vol XIII, pp 339-391.
22. Berman JE, Mellis SJ, Pollock R, Smith CL, Suh H, Heinke B, Kowal C, Surti U, Chess L, Cantor CR, Alt FW. Content and organisation of the human IgH VH locus: definition of three new VH families and linkage to the γ CH locus. EMBO J 1988; 7: 727-738.
23. Buluwela L, Albertson DG, Sherrington P, Rabbitts PH, Spurr N, Rabbitts TH. The use of chromosomal translocation to study the human immunoglobulin gene organisation: mapping DH segments within 35 kb of the Cμ gene and identification of a new DH locus. EMBO J 1988; 7: 2003-2010.
24. Ichihara Y, Matsuoka H, Kurosawa Y. Organisation of the human immunoglobulin heavy chain gene loci. EMBO J 1988; 7: 4141-4150.
25. Ravetch JV, Siebelist U, Korsmeyer SJ, Waldmann T, Leder P. Structure of the human immunoglobulin in locus: characterisation of embryonic and rearranged D genes. Cell 1981; 27: 583-591.
26. Sonntag D, Weingartner B, Grutzamann RA. A member of a novel human DH gene family: DHFL16. Nucleic Acid Res 1989; 17: 1267.
27. Matsuda F, Shin EK, Hirbayashi Y, Nagaoka H, Yoshida MC, Zong SQ, Honjio T. Organisation of the human immunoglobulin heavy chain: duplication of the D5 cluster within the locus and inter chromosomal translocation of variable region segments. EMBO J 1990; 8: 2501-2506.
28. Porfiri E, Seeker-Walker LM, Hoffbrand AV, Hancock JF. DCC tumour suppressor gene is inactivated in hematologic malignancies showing monosomy 18. Blood 1993; 81: 2696-2701.
29. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151-1168.
30. O'Reilly J, Meyer B, Baker D, Herman R, Cannell P, Davies J. Correlation of bone marrow minimal residual disease and apparent isolated extramedullary relapse in childhood acute lymphoblastic leukemia. Leukemia 1995; 15: 624-627.
31. Ouspenskaia MV, Johnston DA, Roberts WM, Estrov Z, Zipf TF. Accurate quantification of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved. Leukemia 1995; 9: 321-328.
32. Coyle LA, Papaioannou M, Yaxley JC, Chim JS, Attard M, Hoffbrand AV, Foroni L. Molecular analysis of the leukaemic B cell in adult and childhood acute lymphoblastic leukaemia. Br J Haematol 1996; 94: 685-693.
33. Steenbergen EJ, Verghagen OJHM, van Leeuwen EF, van den Berg H, Behrendt H, Slater RM, von dem Borne, van der School CE. Prolonged persistence of PCR-detectable residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia. Leukemia 1995; 9: 1726-1734.
34. Papaioannou M, Yaxley JC, Hoffbrand AU, Foroni L. Oligoclonality in acute lymphoblastic leukaemia (ALL): emergence of minor clones rather than change of clonality at relapse in ALL. Br J Haematol 1997; 97 (Suppl. 1): 202a.